---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-002066"
form_type: "8-K"
ticker: "TDOC"
cik: "0001477449"
company_name: "Teladoc Health, Inc."
filed_at: "2023-01-09T23:59:59+00:00"
generated_at: "2026-06-20T17:41:42.173894+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Teladoc pre-announces Q4 revenue $633-640M; FY22 revenue $2.403-2.410B

## Summary
- FY2022 total revenue guided $2.403B-$2.410B, including ~$1B from BetterHelp.
- Q4 2022 revenue expected $633M-$640M; adjusted EBITDA outlook unchanged from prior guidance.
- Preliminary, unaudited figures subject to completion of financial close and audit.
- Company reaffirms adjusted EBITDA outlook consistent with Q3 2022 earnings release.
- Management to present at 41st Annual J.P. Morgan Healthcare Conference on Jan 9, 2023.

## SEC filing metadata
- accession: 0001104659-23-002066
- form_type: 8-K
- ticker: TDOC
- cik: 0001477449
- company_name: Teladoc Health, Inc.
- filed_at: 2023-01-09T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1477449/000110465923002066/0001104659-23-002066-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1477449/000110465923002066/tm232556d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-002066
- JSON: https://secwatch.observer/filing/0001104659-23-002066.json
- Plain text: https://secwatch.observer/filing/0001104659-23-002066.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.